K. L. Zeng

发表

Palliative treatment of metastatic phyllodes tumors: a case series.

E. Rakovitch, D. Vesprini, E. Slodkowska, 2017, AME case reports.

Adverse Radiation Effect After Hypofractionated Stereotactic Radiosurgery in 5 Daily Fractions for Surgical Cavities and Intact Brain Metastases.

M. Ruschin, A. Sahgal, H. Soliman, 2020, International journal of radiation oncology, biology, physics.

Patient preference for stereotactic radiosurgery plus or minus whole brain radiotherapy for the treatment of brain metastases.

S. Lo, A. Sahgal, H. Soliman, 2017, Annals of palliative medicine.

Prognostic Factors Associated With Surviving Less Than 3 Months vs Greater Than 3 Years Specific to Spine Stereotactic Body Radiotherapy and Late Adverse Events

A. Sahgal, H. Soliman, E. Atenafu, 2021, Neurosurgery.

Local control and patterns of failure for “Radioresistant” spinal metastases following stereotactic body radiotherapy compared to a “Radiosensitive” reference

N. Lipsman, M. Ruschin, A. Sahgal, 2021, Journal of Neuro-Oncology.

Bilateral Blindness Following Chemoradiation for Locally Advanced Oropharyngeal Carcinoma

A. Louie, M. Sanatani, S. Kuruvilla, 2015, Cureus.

Stereotactic Body Radiotherapy for Spinal Metastases at the Extreme Ends of the Spine: Imaging-Based Outcomes for Cervical and Sacral Metastases.

C. Whyne, A. Yee, V. Yang, 2018, Neurosurgery.

A retrospective review of phyllodes tumours of the breast: A single institution experience.

Liying Zhang, E. Rakovitch, D. Vesprini, 2018, Breast.

Dose-escalated two-fraction spine stereotactic body radiotherapy: 28 Gy vs. 24 Gy in 2 daily fractions.

M. Ruschin, A. Sahgal, H. Soliman, 2022, International journal of radiation oncology, biology, physics.

Accelerated Hypofractionated Radiotherapy for Centrally Located Lung Tumours Not Suitable for Stereotactic Body Radiotherapy or Chemoradiotherapy.

I. Poon, Y. Ung, A. Louie, 2022, Clinical oncology (Royal College of Radiologists (Great Britain)).

Stereotactic Body Radiotherapy (SBRT) for Oligometastatic Spine Metastases: An Overview

A. Sahgal, H. Soliman, C. Tseng, 2019, Front. Oncol..

Adult Pilocytic Astrocytoma

H. Soliman, K. L. Zeng, 2020, Practical Guides in Radiation Oncology.

Radiotherapy of Skeletal Metastases

O. Sartor, Ø. Bruland, E. Chow, 2018, Primer on the Metabolic Bone Diseases and Disorders of Mineral Metabolism.

Spine Stereotactic Body Radiotherapy for Prostate Cancer Metastases and the Impact of Hormone Sensitivity Status on Local Control

A. Sahgal, H. Soliman, P. Cheung, 2022, Neurosurgery.

30 Gy in 4 Stereotactic Body Radiotherapy Fractions for Complex Spinal Metastases: Mature Outcomes Supporting This Novel Regimen

M. Ruschin, A. Sahgal, H. Soliman, 2023, Neurosurgery.

In Reply to Sari et al.

A. Sahgal, C. Tseng, K. L. Zeng, 2023, International Journal of Radiation Oncology*Biology*Physics.

Mature Local Control and Reirradiation Rates Comparing Spine Stereotactic Body Radiotherapy to Conventional Palliative External Beam Radiotherapy.

W. Parulekar, M. Ruschin, A. Sahgal, 2022, International journal of radiation oncology, biology, physics.

Accelerated Hypofractionated Radiation Therapy for Centrally Located Lung Tumors Not Suitable for Stereotactic Body Radiation Therapy (SBRT) or Concurrent Chemoradiotherapy (CRT)

I. Poon, Y. Ung, P. Cheung, 2018, International Journal of Radiation Oncology*Biology*Physics.

Utility of molecular markers in predicting local control specific to lung cancer spine metastases treated with stereotactic body radiotherapy.

J. Detsky, S. Myrehaug, K. L. Zeng, 2024, Journal of neuro-oncology.